Jim Simons Lantern Pharma Inc. Transaction History
Renaissance Technologies LLC
- $56.7 Billion
- Q2 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Lantern Pharma Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 81,800 shares of LTRN stock, worth $264,214. This represents 0.0% of its overall portfolio holdings.
Number of Shares
81,800
Previous 65,700
24.51%
Holding current value
$264,214
Previous $578,000
33.91%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding LTRN
# of Institutions
40Shares Held
1.27MCall Options Held
42.8KPut Options Held
5.6K-
Vanguard Group Inc Valley Forge, PA364KShares$1.17 Million0.0% of portfolio
-
New Edge Advisors, LLC New Orleans, LA157KShares$507,5100.01% of portfolio
-
Geode Capital Management, LLC Boston, MA86.3KShares$278,9000.0% of portfolio
-
Cm Management, LLC80KShares$258,4000.35% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA59.8KShares$193,0210.0% of portfolio
About Lantern Pharma Inc.
- Ticker LTRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,830,900
- Market Cap $35M
- Description
- Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...